Submitted by web@researchtop... on Mon, 06/28/2010 - 17:57
AMG 386, an Angiogenesis Inhibitor, in the Treatment of Recurrent Ovarian, Peritoneal or Fallopian Tube Carcinoma
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from June 30, 2010) | Subscribe to Dr Love's email alerts | ||
Slides from a presentation at ASCO 2010 and transcribed comments from a recent interview with Robert A Burger, MD (6/16/10)
Karlan BY et al. Randomized, double-blind, placebo-controlled, Phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer. Proc ASCO 2010;Abstract 5000.